Abcam Wins ‘Best Use of Digital Media’ at Life Science Industry Awards
News Nov 19, 2014
Abcam plc. has won the Life Science Industry Award for the ‘Best use of digital media’. Hosted by Bioinformatics LLC, the awards were announced at a ceremony in Washington D.C. on November 18, in conjunction with the Society for Neuroscience Annual Meeting.
Abcam revolutionised the buying of antibodies through its innovative eCommerce platform. The Company continues to innovate through its digital channels to provide personalised, relevant content that anticipates consumer needs and enhances their experience and engagement.
Presented to the world’s top performing life science suppliers in 27 categories, the Life Science Industry Awards are recognised as a benchmark of excellence in the life science tools industry. Voted by an expert network of thousands of global scientists, The Science Advisory Board, the awards bring the voice of the customer into the voting process, backed up by rigorous scoring methodology, bringing these awards the highest degree of integrity.
Alan Hirzel, CEO of Abcam, commented: “We’re delighted to have been recognised for the ‘Best Use of Digital Media’ and nominated in a further six categories. Our consumer-driven digital marketing strategy means we stay at the forefront of consumer needs, to provide the best products and services to enable researchers to discover more.”
Artificial Cellular Compartments BuiltNews
How to install new capabilities in cells without interfering with their metabolic processes? A team from the Technical University of Munich (TUM) and the Helmholtz Zentrum München have altered mammalian cells in such a way that they formed artificial compartments in which sequestered reactions could take place, allowing the detection of cells deep in the tissue and also their manipulation with magnetic fields.READ MORE
Ataxin Links Long Term-Memory and NeurodegenerationNews
Scientists have just discovered that a small region of a cellular protein that helps long-term memories form also drives the neurodegeneration seen in motor neuron disease (MND)READ MORE
BioAscent Establishes Integrated Drug Discovery Services OfferingNews
Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences.READ MORE
Comments | 0 ADD COMMENT
International Conference on Biobetters and Regulatory Affairs
Jun 27 - Jun 28, 2018